Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents: Results From the T-PAS Expanded Access Study.
- Resource Type
- journal article
- Source
- Cancer Journal; Sep/Oct2015, Vol. 21 Issue 5, p357-364, 8p
- Subject
- Language
- ISSN
- 15289117